4.8 Article

Synthesis, characterization, and tumor selectivity of a polyphosphazene-platinum(II) conjugate

期刊

JOURNAL OF CONTROLLED RELEASE
卷 105, 期 1-2, 页码 142-150

出版社

ELSEVIER SCIENCE BV
DOI: 10.1016/j.jconrel.2005.03.016

关键词

polyphosphazene; platinum conjugate; anticancer drug; tumor selectivity

向作者/读者索取更多资源

A new amphiphilic poly(organophosphazene) was synthesized by stepwise nucleophilic substitutions with a hydrophilic methoxy poly(ethylene glycol) with an average molecular weight of 350 (MPEG350) and a hydrophobic glyCyl-L-glutamate as side groups, and then an antitumor (dach)platinum(II) (dach: trans -(+/-)- 1,2-diaminocyclohexane) moiety was conjugated to the polymer using the dipeptide as a spacer. This polymeric platinum conjugate was found to be accumulated in the tumor tissue to a remarkably greater extent than in the normal tissue (tumor/tissue ratio > 4), probably due to the excellent EPR effect and the long circulating properties of the polymer conjugate (t(1/2 beta)=6.2 h and AUC=4020 nmol h/ml) compared with carboplatin ((1/2 beta) =0.42 h and AUC=120 nmol h/ml). The polymer conjugate also exhibited high in vitro cytotoxicity comparable to cisplatin against several human tumor cells tested. (c) 2005 Elsevier B.V. All rights reserved.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.8
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据